Endometrial cancer

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 26, Issue 3, 2012, Pages 311-324

  Arora, Vivek ^a   Quinn, Michael A ^a,b  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

conservative management; endometrial cancer; fertility sparing treatment

Indexed keywords

GESTAGEN; GONADORELIN DERIVATIVE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PROGESTERONE; TAMOXIFEN;

ARTICLE; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INVASION; CONSERVATIVE TREATMENT; ENDOMETRIUM CARCINOMA; FEMALE FERTILITY; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT PLANNING; TUMOR DIFFERENTIATION;

ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY PRESERVATION; HUMANS; HYSTEROSCOPY; LYMPHATIC METASTASIS; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; OVARIAN NEOPLASMS; PATIENT SELECTION; PREGNANCY; PREGNANCY RATE; PROGESTINS; PROGNOSIS;

EID: 84860218597     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2011.12.007     Document Type: Article

References (57)

1. Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. http://seer.cancer. gov/faststats. [accessed on 12.12.2011].
2. B.N. Tran, P.P. Connell, and S. Waggoner Characteristics and outcome of endometrial carcinoma patients age 45 years and younger Am J Clin Oncol 23 2000 476 480 (Pubitemid 32429124)
3. P.T. Soliman, J.C. Oh, and K.M. Schmeler Risk factors for young premenopausal women with endometrial cancer Obstet Gynecol 105 2005 575 580 (Pubitemid 40271225)
4. K.M. Schmeler, and K.H. Lu Gynecologic cancers associated with Lynch syndrome/HNPCC Clin Transl Oncol 10 2008 313 317
5. M.M. Shah, and J.D. Wright Management of endometrial cancer in young women Clin Obstet Gynecol 54 2011 219 225
6. M. Frumovitz, and D.M. Gershenson Fertility-sparing therapy for young women with endometrial cancer Expert Rev Anticancer Ther 6 2006 27 32
7. I. Navarria, M. Usel, and E. Rapiti Young patients with endometrial cancer: How many could be eligible for fertility-sparing treatment? Gynecol Oncol 114 2009 448 451
8. K. Yamazawa, M. Hirai, and A. Fujito Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer Hum Reprod 22 2007 1953 1958 (Pubitemid 47062765)
9. A.A. Shamshirsaz, M. Withiam-Leitch, and K. Odunsi Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review Gynecol Oncol 104 2007 757 760 (Pubitemid 46240271)
10. C. Walsh, C. Holschneider, and Y. Hoang Coexisting ovarian malignancy in young women with endometrial cancer Obstet Gynecol 106 2005 693 699 (Pubitemid 41362170)
11. R. Zaino, C. Whitney, and M.F. Brady Simultaneously detected endometrial and ovarian carcinomas: a prospective clinicopathologic study of 74 cases: a Gynecologic Oncology Group Study Gynecol Oncol 83 2001 355 362 (Pubitemid 33033079)
12. E.R. Evans-Metcalf, S.E. Brooks, and F.R. Reale Profile of women 45 years of age and younger with endometrial cancer Obstet Gynecol 91 1998 349 354 (Pubitemid 28119833)
13. L. Minig, D. Franchi, and S. Boveri Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women Ann Oncol 22 2011 643 649
14. W.T. Creasman, C.P. Morrow, and B.N. Bundy Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 8 Suppl. 1987 2035 2041 (Pubitemid 17145924)
15. D.S. Chi, R.R. Barakat, and M.J. Palayekar The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology Int J Gynecol Cancer 18 2008 269 273 (Pubitemid 351365228)
16. M.A. Quinn, B.J. Kneale, and D.W. Fortune Endometrial carcinoma in premenopausal women: a clinicopathological study Gynecol Oncol 20 1985 298 306 (Pubitemid 15143755)
17. K. Yamazawa, K. Seki, and H. Matsui Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature Int J Gynecol Cancer 10 2000 212 222 (Pubitemid 30626974)
18. T. Yasumizu, K. Ogawa, and J. Kato Comparison of the clinicopathological characteristics of premenopausal and postmenopausal endometrial carcinomas: analysis of endocrinologically evaluated cases Jpn J Clin Oncol 26 1996 152 156 (Pubitemid 126472312)
19. N.K. Lee, M.K. Cheung, and J.Y. Shin Prognostic factors for uterine cancer in reproductive-aged women Obstet Gynecol 109 2007 655 662 (Pubitemid 46339405)
20. M.M. Leitao Jr., S. Kehoe, and R.R. Barakat Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma Gynecol Oncol 113 2009 105 108
21. D.M. Larson, K.K. Johnson, and S.K. Broste Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer Obstet Gynecol 86 1995 38 42
22. S.M. Jacques, F. Qureshi, and A. Munkarah Interinstitutional surgical pathology review in gynecologic oncology: I. Cancer in endometrial curettings and biopsies Int J Gynecol Pathol 17 1998 36 41 (Pubitemid 28016700)
23. S.M. Jacques, F. Qureshi, and A. Munkarah Interinstitutional surgical pathology review in gynecologic oncology: II. Endometrial cancer in hysterectomy specimens Int J Gynecol Pathol 17 1998 42 45 (Pubitemid 28016701)
24. S. Yang, K.W. Thiel, and K.K. Leslie Progesterone: the ultimate endometrial tumor suppressor Trends Endocrinol Metabol 22 2011 145 152
25. C.-H. Lai, and H.-J. Huang The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer Curr Opin Obstet Gynecol 18 2006 29 34
26. I. Mazzon, G. Corrado, and V. Masciullo Conservative surgical management of stage IA endometrial carcinoma for fertility preservation Fertil Steril 93 2010 1286 1289
27. T. Song, J.-W. Lee, and H.-J. Kim Prognostic significance of DNA ploidy in stage I endometrial cancer Gynecol Oncol 122 2011 79 82
28. A. Gadducci, N. Spirito, and E. Baroni The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option Gynecol Endocrinol 25 2009 683 691
29. L. Savelli, M. Ceccarini, and M. Ludovisi Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging Ultrasound Obstet Gynecol 31 2008 560 566
30. M.J. Zerbe, R. Bristow, and F.C. Grumbine Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer Gynecol Oncol 78 2000 67 70 (Pubitemid 30439482)
31. T.J. Selman, C.H. Mann, and J. Zamora A systematic review of tests for lymph node status in primary endometrial cancer BMC Women's Health 8 2008 8
32. E. Sala, A. Rockall, and D. Rangarajan The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis Eur J Radiol 76 2010 367 385
33. T.J. Cade, M.A. Quinn, and O.M. McNally Predictive value of magnetic resonance imaging in assessing myometrial invasion in endometrial cancer Int J Gynecol Cancer 20 2010 1166 1169
34. E. Sala, R. Crawford, and E. Senior Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma Int J Gynecol Cancer 19 2009 141 146
35. C. Vasconcelos, A. Félix, and T.M. Cunha Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation J Obstet Gynaecol 27 2007 65 70
36. N. Rasool, and P.G. Rose Fertility-preserving surgical procedures for patients with gynecologic malignancies Clin Obstet Gynecol 53 2010 804 814
37. A.G. Rockall, S.A. Sohaib, and M.G. Harisinghani Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer J Clin Oncol 23 2005 2813 2821 (Pubitemid 46179472)
38. N.S. Horowitz, F. Dehdashti, and T.J. Herzog Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer Gynecol Oncol 95 2004 546 551 (Pubitemid 39592519)
39. E. Inubashiri, K. Hata, and K. Kanenishi Positron emission tomography with the glucose analog [18F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: Comparison with CT and MRI findings J Obstet Gynaecol Res 35 2009 26 34
40. M. Saegusa, and I. Okayasu Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis Cancer 83 1998 111 121 (Pubitemid 28299636)
41. T.C. Randall, and R.J. Kurman Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 Obstet Gynecol 90 1997 434 440 (Pubitemid 27357938)
42. H.-S. Hahn, S.-G. Yoon, and J.-S. Hong Conservative Treatment With Progestin and Pregnancy Outcomes in Endometrial Cancer Int J Gynecol Cancer 19 2009 1068 1073
43. L. Chiva, F. Lapuente, and L. González-Cortijo Sparing fertility in young patients with endometrial cancer Gynecol Oncol 111 Suppl. 2008 S101 S104
44. T. Cade, M. Quinn, and R. Rome Progestogen treatment options for early endometrial cancer BJOG 117 2010 879 884
45. P.T. Ramirez, M. Frumovitz, and D.C. Bodurka Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review Gynecol Oncol 95 2004 133 138 (Pubitemid 39286288)
46. K. Ushijima, H. Yahata, and H. Yoshikawa Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women J Clin Oncol 25 2007 2798 2803 (Pubitemid 47123189)
47. F.J. Montz, R.E. Bristow, and A. Bovicelli Intrauterine progesterone treatment of early endometrial cancer Am J Obstet Gynecol 186 2002 651 657 (Pubitemid 34494341)
48. D.T. Wheeler, R.E. Bristow, and R.J. Kurman Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins Am J Surg Pathol 31 2007 988 998 (Pubitemid 47012294)
49. S. Erkanli, and A. Ayhan Fertility-sparing therapy in young women with endometrial cancer Int J Gynecol Cancer 20 2010 1170 1187
50. T.J. Cade, M.A. Quinn, and R.M. Rome Progestogen treatment options for endometrial cancer BJOG 117 2010 879 884
51. E. Suh-Burgmann, Y.-Y. Hung, and M.A. Armstrong Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage Obstet Gynecol 114 2009 523 529
52. A. Ørbo, M. Arnes, and C. Hancke Treatment results of endometrial hyperplasia after prospective D-score classification Gynecol Oncol 111 2008 68 73
53. V. Sparac, B. Ujević, and M. Ujević Successful pregnancy after hysteroscopic removal of grade I endometrial carcinoma in a young woman with Lynch syndrome Int J Gynecol Cancer 16 Suppl. 1 2006 442 445
54. D.E.S. Boks, A.P. Trujillo, and A.C. Voogd Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer Int J Cancer 102 2002 198 200 (Pubitemid 35168036)
55. K.K. Shih, K. Garg, and D.A. Levine Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40 years of age or younger Gynecol Oncol 123 2011 88 94
56. S. Tangjitgamol, S. Manusirivithaya, and J. Hanprasertpong Fertility-Sparing in Endometrial Cancer Gynecol Obstet Invest 67 2009 250 268
57. M.P. Lowe, B.C. Cooper, and A.K. Sood Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia Gynecol Oncol 91 2003 569 572 (Pubitemid 38388152)